Rocket Lab Stock’s Next Leg Rides On A Vehicle That Has Not Flown Yet

Rocket Lab's backlog is expected to convert into revenue faster than it was, and the vehicle that would compound that has not yet left the ground.

Rocket Lab (RKLB) has returned 86.6% over the trailing twelve months and given back 39.5% over the trailing three months, leaving it about 47% below its 52-week high. The case for the next leg up does not rest on the record $234 million quarter behind it. It rests on one vehicle that has not flown, and on how much sooner the work already sold is due to land.

Neutron Is Priced Like A Different Business Than Electron

Rocket Lab's revenue over the trailing twelve months was $0.77 billion. Neutron, its medium-lift vehicle, came to market at an average selling price of $50 million to $55 million a launch, with a commitment to no significant discounting for early flights; the commercial Electron missions sitting in backlog averaged about $8.5 million each as of the company's first-quarter 2026 update. Demand is arriving before Neutron flies. The Space Force has booked a dedicated Neutron launch for its space-based airborne moving target indicator program, and Kepler Communications has booked a whole rocket for its constellation instead of a rideshare slot, the first time Kepler has done so.

A Bigger Share Of Backlog Is Expected To Convert Within Twelve Months

Backlog reached $2.36 billion at the end of the second quarter of 2026, up from about $2.2 billion three months earlier, which is the less interesting half of it. The share management expects to convert into revenue within the next twelve months moved to 45.5% from 36%, which puts roughly $1.07 billion of contracted work into the next twelve months, up from roughly $0.79 billion on the prior quarter's mix and more than Rocket Lab's entire revenue over the trailing twelve months. Each of those dollars lands on a cost base that has improved: operating margin at -29.1% over the trailing twelve months against a three-year average of -48.6%. Growth without a positive margin behind it is the reason the Trefis High Quality Portfolio looks for both together in its holdings.

The Upside Now Narrows To Neutron's Pad Arrival and Launch Timing

Cash is the honest counter. Free cash flow on the company's own definition was a use of $110.1 million in the second quarter of 2026 against $77.4 million in the first quarter, and management has guided that use of cash to stay elevated in the third quarter of 2026. The roughly $2.4 billion of liquidity is not free runway either: the $1.08 billion at-the-market stock sale that lifted it is intended to support acquisitions including the pending Iridium Communications purchase. So the upside narrows to a date.

Management's own sequence puts adjusted EBITDA positive in the quarter after Neutron's first successful test flight and cash generation roughly eighteen to twenty-four months after that on a stand-alone basis, before any Iridium contribution, while Neutron is targeted for delivery to the pad in the fourth quarter of 2026, with the window for a launch before year-end narrowing by the company's own account. Until it flies, guidance is the tell: Rocket Lab has guided the third quarter of 2026 to roughly 10% sequential revenue growth at the midpoint and to an adjusted EBITDA loss of $17 million to $23 million, wider than the second quarter's $8.8 million, and whether that step-up keeps landing is what to track.

Finding Winners Is Half The Job, Keeping The Gains Is The Other

Spotting the opportunity is the enjoyable half of investing, keeping what it earns is the half that compounds. A position that has grown large enough to matter is worth sizing deliberately rather than by accident. What a position that size would do to your net worth is exactly what the Trefis Wealth team computes, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.